HEALTHTECH
M
E
D
T
E
C
H
Where medical innovators turn vision into reality
MedTech Actuator empowers founders to turn big health ideas into global impact, accelerating innovation, connecting ecosystems, and helping you scale with purpose.
Join a Program Today
From idea to impact, explore MedTech Actuator programs designed to help founders shape the future of health.
Real founders. Real impact.
Hear directly from healthcare innovators who’ve accelerated their journey with the MedTech Actuator
Professor Nick Opie
Founding Director & CTO, Synchron
Since the MedTech Actuator we've raised a total of over $345M, expanded into the US, commenced first in-human trials and even received a mention for the work we are doing from President Obama. We were researchers with a vision for a groundbreaking minimally invasive brain-computer interface to overcome paralysis, but we didn't know the business of building a company and taking a product to market. The MedTech Actuator Origin gave us a crash course in critical topics like sharpening our value proposition, pitching to investors and developing a robust business model and IP strategy. We vastly expanded our network and the Gala pitch was a highly visible launch pad that positioned us for future growth.
More
Professor Nick Opie
Founding Director & CTO, Synchron
Since the MedTech Actuator we've raised a total of over $345M, expanded into the US, commenced first in-human trials and even received a mention for the work we are doing from President Obama. We were researchers with a vision for a groundbreaking minimally invasive brain-computer interface to overcome paralysis, but we didn't know the business of building a company and taking a product to market. The MedTech Actuator Origin gave us a crash course in critical topics like sharpening our value proposition, pitching to investors and developing a robust business model and IP strategy. We vastly expanded our network and the Gala pitch was a highly visible launch pad that positioned us for future growth.
More
Professor Nick Opie
Founding Director & CTO, Synchron
Since the MedTech Actuator we've raised a total of over $345M, expanded into the US, commenced first in-human trials and even received a mention for the work we are doing from President Obama. We were researchers with a vision for a groundbreaking minimally invasive brain-computer interface to overcome paralysis, but we didn't know the business of building a company and taking a product to market. The MedTech Actuator Origin gave us a crash course in critical topics like sharpening our value proposition, pitching to investors and developing a robust business model and IP strategy. We vastly expanded our network and the Gala pitch was a highly visible launch pad that positioned us for future growth.
More
Ajit Ravindran
Founder & CEO, Lenexa Medical
Through the MedTech Actuator, we were able to take our innovative idea from concept to a commercialready connected care solution, LenexaCARE.
More
Ajit Ravindran
Founder & CEO, Lenexa Medical
Through the MedTech Actuator, we were able to take our innovative idea from concept to a commercialready connected care solution, LenexaCARE.
More
Amy Yu
Founder & CTO, Ventora Medical
The MedTech Actuator Origin prize money enabled us to incorporate Ventora Medical, submit our provisional patent application and partner with a product development specialist. The competition was a 'pressure test' of our product and business outside of the university setting where we first developed our idea - and a gateway into the MedTech Actuator.
More
Amy Yu
Founder & CTO, Ventora Medical
The MedTech Actuator Origin prize money enabled us to incorporate Ventora Medical, submit our provisional patent application and partner with a product development specialist. The competition was a 'pressure test' of our product and business outside of the university setting where we first developed our idea - and a gateway into the MedTech Actuator.
More
Amy Yu
Founder & CTO, Ventora Medical
The MedTech Actuator Origin prize money enabled us to incorporate Ventora Medical, submit our provisional patent application and partner with a product development specialist. The competition was a 'pressure test' of our product and business outside of the university setting where we first developed our idea - and a gateway into the MedTech Actuator.
More
Anshul Dayal
Founder & CEO, Neuromersiv
Since graduating from the Accelerator program in 2020 we have raised AUD$1.5M in pre-seed capital, completed Phase 0 clinical trials, completed regulatory approvals of our product from the Australian TGA & UK MHRA and built key commercial partnerships with leading rehabilitation providers in Australia, India & the United Kingdom.
More
Anshul Dayal
Founder & CEO, Neuromersiv
Since graduating from the Accelerator program in 2020 we have raised AUD$1.5M in pre-seed capital, completed Phase 0 clinical trials, completed regulatory approvals of our product from the Australian TGA & UK MHRA and built key commercial partnerships with leading rehabilitation providers in Australia, India & the United Kingdom.
More
Anshul Dayal
Founder & CEO, Neuromersiv
Since graduating from the Accelerator program in 2020 we have raised AUD$1.5M in pre-seed capital, completed Phase 0 clinical trials, completed regulatory approvals of our product from the Australian TGA & UK MHRA and built key commercial partnerships with leading rehabilitation providers in Australia, India & the United Kingdom.
More
Anshul Dayal
Founder & CEO, Neuromersiv
Since graduating from the Accelerator program in 2020 we have raised AUD$1.5M in pre-seed capital, completed Phase 0 clinical trials, completed regulatory approvals of our product from the Australian TGA & UK MHRA and built key commercial partnerships with leading rehabilitation providers in Australia, India & the United Kingdom.
More
Discover our ecosystem
Powered by a global network of mentors, partners, and supporters, our ecosystem connects founders with the expertise and opportunities to drive real-world health impact.
